<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156576">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02148692</url>
  </required_header>
  <id_info>
    <org_study_id>ANE-PROBESE</org_study_id>
    <nct_id>NCT02148692</nct_id>
  </id_info>
  <brief_title>Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients</brief_title>
  <acronym>PROBESE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Dresden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ABC Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VU University of Amsterdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Foggia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Eloi University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tel Aviv Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uniuversity of Genua, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative respiratory failure, particularly after surgery under general anesthesia, adds
      to the morbidity and mortality of surgical patients. Anesthesiologists inconsistently use
      positive end-expiratory pressure (PEEP) and recruitment maneuvers in the hope that this may
      improve oxygenation and protect against postoperative pulmonary complications (PPCs),
      especially in obese patients. While anesthesiologists tend to use PEEP higher than in
      non-obese patients. While it is uncertain whether a strategy that uses higher levels of PEEP
      with recruitment maneuvers truly prevents PPCs in these patients, use of higher levels of
      PEEP with recruitment maneuvers could compromise intra-operative hemodynamics.

      The investigators aim to compare a ventilation strategy using higher levels of PEEP with
      recruitment maneuvers with one using lower levels of PEEP without recruitment maneuvers in
      obese patients at an intermediate-to-high risk for PPCs.

      We hypothesize that an intra-operative ventilation strategy using higher levels of PEEP and
      recruitment maneuvers, as compared to ventilation with lower levels of PEEP without
      recruitment maneuvers, prevents PPCs in obese patients at an intermediate-to-high risk for
      PPC.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Postoperative pulmonary complications</measure>
    <time_frame>Five postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital-free days at day 90</measure>
    <time_frame>90 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality at day 90</measure>
    <time_frame>90 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative extra-pulmonary complications</measure>
    <time_frame>Five postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative wound healing</measure>
    <time_frame>Five postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative complications</measure>
    <time_frame>Surgery period</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>complications related to the ventilation strategy (for example: de-saturation, defined as SpO2 ≤ 92%, for &gt; 1 min; hypotension during recruitment maneuvers, as defined by systolic arterial pressure &lt; 90 mmHg for &gt; 2 min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for postoperative ventilatory support</measure>
    <time_frame>Five postoperative days</time_frame>
    <safety_issue>No</safety_issue>
    <description>invasive or non-invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unexpected need for ICU admission or ICU readmission within 30 days</measure>
    <time_frame>Five postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for hospital readmission within 30 days</measure>
    <time_frame>30 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">748</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Surgery</condition>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>Higher PEEP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEP of 12 cmH2O or higher and lung recruitment maneuvers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower PEEP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PEEP of 4 cmH2O without lung recruitment maneuvers</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Higher PEEP</intervention_name>
    <arm_group_label>Higher PEEP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lower PEEP</intervention_name>
    <arm_group_label>Lower PEEP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled for open or laparoscopic surgery under general anesthesia

          -  Intermediate-to-high risk for PPCs following surgery, according to the ARISCAT risk
             score (≥ 26)

          -  BMI ≥ 35 kg/m2

          -  Expected duration of surgery ≥ 2 h

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Previous lung surgery (any)

          -  Persistent hemodynamic instability, intractable shock (considered hemodynamically
             unsuitable for the study by the patient's managing physician)

          -  History of previous severe chronic obstructive pulmonary disease (COPD) (non-invasive
             ventilation and/or oxygen therapy at home, repeated systemic corticosteroid therapy
             for acute exacerbations of COPD)

          -  Recent immunosuppressive medication (patients receiving chemotherapy or radiation
             therapy up to two months prior to surgery)

          -  Severe cardiac disease (New York Heart Association class III or IV, acute coronary
             syndrome or persistent ventricular tachyarrhythmias)

          -  Invasive mechanical ventilation longer than 30 minutes (e.g., general anesthesia for
             surgery) within last 30 days

          -  Pregnancy (excluded by anamneses and/or laboratory analysis)

          -  Prevalent acute respiratory distress syndrome expected to require prolonged
             postoperative mechanical ventilation

          -  Severe pulmonary arterial hypertension, defined as systolic pulmonary artery pressure
             &gt; 40 mmHg

          -  Intracranial injury or tumor

          -  Neuromuscular disease (any)

          -  Need for intraoperative prone or lateral decubitus position

          -  Need for one-lung ventilation

          -  Cardiac surgery

          -  Neurosurgery

          -  Planned reintubation following surgery

          -  Enrolled in other interventional study or refusal of informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcelo Gama de Abreu, MD, PhD</last_name>
    <phone>+493514584488</phone>
    <email>mgabreu@uniklinikum-dresden.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Bluth, MD</last_name>
    <phone>+4935145818007</phone>
    <email>thomas.bluth@uniklinikum-dresden.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care, University Hospital Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
